<DOC>
	<DOCNO>NCT00964626</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , paclitaxel cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . PURPOSE : This phase II trial study side effect give paclitaxel together cisplatin first-line therapy see well work treat patient stage I , stage II , stage III , stage IV ovarian epithelial cancer .</brief_summary>
	<brief_title>Paclitaxel Cisplatin First-Line Treatment Patients With Stage I , Stage II , Stage III , Stage IV Ovarian Epithelial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To investigate efficacy safety paclitaxel cisplatin first-line chemotherapy patient stage IC-IV ovarian epithelial cancer . OUTLINE : This multicenter study . Patients receive paclitaxel IV cisplatin IV every 2 week . Treatment repeat every 2 week 9 course absence disease progression unacceptable toxicity .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm epithelial adenocarcinoma ovary Stage ICIV disease No known clinical evidence brain metastasis PATIENT CHARACTERISTICS : ECOG performance status 02 Hemoglobin must ≥ 90 g/L ANC ≥ 2 x 10^9/L Platelet count ≥ 100 x10^9/L Serum creatinine ≤ 115 μmol/L Total bilirubin ≤ 25 μmol/L Not pregnant nursing No serious disease could affect protocol compliance result No prior malignancy within past 5 year except curatively treat carcinoma situ cervix squamous carcinoma skin No peripheral neuropathy ≥ CTCAE version 3.0 grade 2 No know hypersensitivity study drug excipients No drug addiction alcoholism No disorder lead condition contraindicates use investigational drug , may affect patient 's compliance study requirement PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy ovarian cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>stage IA ovarian epithelial cancer</keyword>
	<keyword>stage IB ovarian epithelial cancer</keyword>
	<keyword>stage IC ovarian epithelial cancer</keyword>
	<keyword>stage IIA ovarian epithelial cancer</keyword>
	<keyword>stage IIB ovarian epithelial cancer</keyword>
	<keyword>stage IIC ovarian epithelial cancer</keyword>
	<keyword>stage IIIA ovarian epithelial cancer</keyword>
	<keyword>stage IIIB ovarian epithelial cancer</keyword>
	<keyword>stage IIIC ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
</DOC>